Real-world insights into non-small cell lung cancer patients with MET exon 14 skipping mutations: A Swedish retrospective study from two university hospitals

被引：0
|
作者：
Skribek, M. [1 ]
Brunnstrom, H. [2 ]
Aricak, O. [3 ]
Planck, M. [4 ]
Jatta, K. [5 ]
Oskarsdottir, G. N. [4 ]
Naserhojati, H. [6 ]
Haglund, F. [7 ]
Ekman, S. [8 ]
机构：
[1] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[2] Lund Univ, Div Pathol, Lund, Sweden
[3] Karolinska Univ Hosp, Dept Pathol & Cytol, Solna, Sweden
[4] Lund Univ, Div Oncol, Lund, Sweden
[5] Karolinska Univ Hosp Solna, Dept Pathol & Cytol, Solna, Sweden
[6] Karolinska Univ Hosp, Dept Pathol & Cytol, Huddinge, Sweden
[7] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[8] Karolinska Inst, Dept Oncol Pathol, Solna, Sweden
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1302
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1179P
引用
收藏
页码：S1087 / S1087
页数：1
相关论文
共 50 条
  • [21] Real world experience with MET inhibitors in MET exon 14 skipping mutated non-small cell lung cancer: largest Indian perspective
    Batra, Ullas
    Singh, Ajay Kumar
    Nathany, Shrinidhi
    Dewan, Abhinav
    Sharma, Mansi
    Amrith, B. P.
    Mehta, Anurag
    Batra, Vanshika
    Noronha, Vanita
    Prabhash, Kumar
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [22] Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
    Paik, Paul K.
    Felip, Enriqueta
    Veillon, Remi
    Sakai, Hiroshi
    Cortot, Alexis B.
    Garassino, Marina C.
    Mazieres, Julien
    Viteri, Santiago
    Senellart, Helene
    Van Meerbeeck, Jan
    Raskin, Jo
    Reinmuth, Niels
    Conte, Pierfranco
    Kowalski, Dariusz
    Cho, Byoung Chul
    Patel, Jyoti D.
    Horn, Leora
    Griesinger, Frank
    Han, Ji-Youn
    Kim, Young-Chul
    Chang, Gee-Chen
    Tsai, Chen-Liang
    Yang, James C. -H.
    Chen, Yuh-Min
    Smit, Egbert F.
    van der Wekken, Anthonie J.
    Kato, Terufumi
    Juraeva, Dilafruz
    Stroh, Christopher
    Bruns, Rolf
    Straub, Josef
    Johne, Andreas
    Scheele, Juergen
    Heymach, John V.
    Le, Xiuning
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (10): : 931 - 943
  • [23] Capmatinib for patients with non-small cell lung cancer with MET exon 14 skipping mutations: A review of preclinical and clinical studies
    Wu, Yi-Long
    Smit, Egbert F.
    Bauer, Todd M.
    CANCER TREATMENT REVIEWS, 2021, 95
  • [24] MET exon 14 skipping mutations in advanced non-small cell lung cancer (NSCLC) are not associated with MET amplification and overexpression
    Gimenez-Capitan, Ana
    Teixido, Cristina
    Aguado, Cristina
    Rodriguez, Sonia
    Bertran-Alamillo, Jordi
    Castellvi, Josep
    Yeste, Zaira
    Perez, Ana
    Rosell, Rafael
    Molina-Vila, Miguel Angel
    CANCER RESEARCH, 2017, 77
  • [25] The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping
    Salgia, Ravi
    Sattler, Martin
    Scheele, Juergen
    Stroh, Christopher
    Felip, Enriqueta
    CANCER TREATMENT REVIEWS, 2020, 87
  • [26] DEMONSTRATING INTERNAL AND EXTERNAL VALIDITY IN REAL-WORLD DATASETS: A CASE STUDY IN MET EXON 14 (METEX14) SKIPPING NON-SMALL CELL LUNG CANCER (NSCLC)
    Batteson, R.
    Hook, E.
    Vioix, H.
    Hatswell, A.
    VALUE IN HEALTH, 2022, 25 (12) : S458 - S458
  • [27] Novel MET exon 14 skipping analogs characterized in non-small cell lung cancer patients: A case study
    Shi, Minke
    Ma, Jing
    Feng, Meilin
    Liang, Lei
    Chen, Hongyuan
    Wang, Tao
    Xie, Zhenghua
    CANCER GENETICS, 2021, 256 : 62 - 67
  • [28] Clinicopathologic Characteristics of Non-Small Cell Lung Carcinomas Harboring MET Exon 14 Skipping Mutations
    Fujii, T.
    Uruga, H.
    Nakamura, N.
    Kohno, T.
    Kishi, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2254 - S2255
  • [29] Analysis of MET Exon 14 Skipping Mutations and MET Gene Amplifications in Non Small-Cell Lung Cancer Patients
    Salido, Marta
    Clave, Sergi
    Dalmases, Alba
    Pijuan, Lara
    Longaron, Raquel
    Lorenzo, Marta
    Taus, Alvaro
    Torres, Erica
    Rocha, Pedro
    Espinet, Blanca
    Bellosillo, Beatriz
    Arriola, Edurne
    MODERN PATHOLOGY, 2018, 31 : 749 - 749
  • [30] Analysis of MET Exon 14 Skipping Mutations and MET Gene Amplifications in Non Small-Cell Lung Cancer Patients
    Salido, Marta
    Clave, Sergi
    Dalmases, Alba
    Pijuan, Lara
    Longaron, Raquel
    Lorenzo, Marta
    Taus, Alvaro
    Torres, Erica
    Rocha, Pedro
    Espinet, Blanca
    Bellosillo, Beatriz
    Arriola, Edurne
    LABORATORY INVESTIGATION, 2018, 98 : 749 - 749
12345